Import alert: Ranbaxy facilities.
- Published in:
- 2008
- Publication type:
- Journal Article
Works matching IS 10109609 AND DT 2008 AND VI 22 AND IP 3
Results: 50
1
2
Recombinant human bone morphogenetic protein: life-threatening complications.
- Published in:
- 2008
- Publication type:
- Journal Article
3
Simvastatin used with amiodarone: rhabdomyolysis.
- Published in:
- 2008
- Publication type:
- Journal Article
4
Ceftriaxone: fatal outcome with calcium-containing solutions.
- Published in:
- 2008
- Publication type:
- Journal Article
5
Development of medicines for Alzheimer and Parkinson disease.
- Published in:
- 2008
- Publication type:
- Journal Article
6
African Medicines Regulatory Harmonization Initiative (AMRHI): a WHO concept paper.
- Published in:
- 2008
- Publication type:
- Journal Article
7
Adalimumab: hepatosplenic T-cell lymphoma.
- Published in:
- 2008
- Publication type:
- Journal Article
8
Deferasirox: hepatic failure.
- Published in:
- 2008
- Publication type:
- Journal Article
9
Fluoroquinolones: risk of tendinitis and tendon rupture.
- Published in:
- 2008
- Publication type:
- Journal Article
10
Moxifloxacin: adverse hepatic reactions.
- Published in:
- 2008
- Publication type:
- Journal Article
11
GMP regulations for radiopharmaceuticals.
- Published in:
- 2008
- Publication type:
- Journal Article
12
Desmopressin and hyponatraemia.
- Published in:
- 2008
- Publication type:
- Journal Article
13
International harmonization: ICH Pharmaceutical Quality System Q10.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
14
Medicines Prequalification Programme: listed products.
- Published in:
- 2008
- Publication type:
- Journal Article
15
Safety review of tumour necrosis factor blockers.
- Published in:
- 2008
- Publication type:
- Journal Article
16
Naltrexone injection site reactions.
- Published in:
- 2008
- Publication type:
- Journal Article
17
Abacavir: hypersensitivity reactions.
- Published in:
- 2008
- Publication type:
- Journal Article
18
Pharmaceutical distribution and trade: WHO Certification Scheme on the quality of pharmaceutical products moving in international commerce.
- Published in:
- 2008
- Publication type:
- Journal Article
19
Electronic medical devices malfunction: computed tomography scanning.
- Published in:
- 2008
- Publication type:
- Journal Article
20
Micro-bubble contrast agents.
- Published in:
- 2008
- Publication type:
- Journal Article
21
International Nonproprietary Names for Pharmaceutical Substances (INN)
- Published in:
- 2008
- Publication type:
- Journal Article
22
Medicines Prequalification Programme: listed products.
- Published in:
- WHO Drug Information, 2008, v. 22, n. 3, p. 204
- Publication type:
- Article
23
WHO prequalification: GMP deviations and suspension.
- Published in:
- 2008
- Publication type:
- Journal Article
24
Proposal for improvement of the WHO Certification Scheme.
- Published in:
- WHO Drug Information, 2008, v. 22, n. 3, p. 207
- Publication type:
- Article
25
Serious risks/new safety information.
- Published in:
- 2008
- Publication type:
- Journal Article
26
GMP regulations for radiopharmaceuticals.
- Published in:
- WHO Drug Information, 2008, v. 22, n. 3, p. 205
- Publication type:
- Article
27
Development of medicines for Alzheimer and Parkinson disease.
- Published in:
- WHO Drug Information, 2008, v. 22, n. 3, p. 205
- Publication type:
- Article
28
Consultation on improvement of the Certification Scheme.
- Published in:
- WHO Drug Information, 2008, v. 22, n. 3, p. 214
- Publication type:
- Article
29
Import alert: Ranbaxy facilities.
- Published in:
- WHO Drug Information, 2008, v. 22, n. 3, p. 203
- Publication type:
- Article
30
WHO Prequalification: GMP deviations and suspension.
- Published in:
- WHO Drug Information, 2008, v. 22, n. 3, p. 203
- Publication type:
- Article
31
Colchicine: fatal interactions and reactions.
- Published in:
- 2008
- Publication type:
- Excerpt
32
Fluoroquinolones: risk of tendinitis and tendon rupture.
- Published in:
- WHO Drug Information, 2008, v. 22, n. 3, p. 200
- Publication type:
- Article
33
Abacavir: hypersensitivity reactions.
- Published in:
- WHO Drug Information, 2008, v. 22, n. 3, p. 200
- Publication type:
- Article
34
Deferasirox: hepatic failure.
- Published in:
- WHO Drug Information, 2008, v. 22, n. 3, p. 199
- Publication type:
- Article
35
Serious Risks/New Safety Information.
- Published in:
- WHO Drug Information, 2008, v. 22, n. 3, p. 198
- Publication type:
- Article
36
Adalimumab: hepatosplenic T-cell lymphoma.
- Published in:
- WHO Drug Information, 2008, v. 22, n. 3, p. 198
- Publication type:
- Article
37
Ceftriaxone: fatal outcome with calcium-containing solutions.
- Published in:
- WHO Drug Information, 2008, v. 22, n. 3, p. 193
- Publication type:
- Article
38
Norfloxacin-containing medicines not for use in urinary infections.
- Published in:
- WHO Drug Information, 2008, v. 22, n. 3, p. 192
- Publication type:
- Article
39
Ezetimibe/simvastatin: safety review of cancer risk.
- Published in:
- WHO Drug Information, 2008, v. 22, n. 3, p. 191
- Publication type:
- Article
40
Moxifloxacin: adverse hepatic reactions.
- Published in:
- WHO Drug Information, 2008, v. 22, n. 3, p. 191
- Publication type:
- Article
41
Safety review of tumour necrosis factor blockers.
- Published in:
- WHO Drug Information, 2008, v. 22, n. 3, p. 194
- Publication type:
- Article
42
Naltrexone injection site reactions.
- Published in:
- WHO Drug Information, 2008, v. 22, n. 3, p. 197
- Publication type:
- Article
43
Simvastatin used with amiodarone: rhabdomyolysis.
- Published in:
- WHO Drug Information, 2008, v. 22, n. 3, p. 197
- Publication type:
- Article
44
Micro-bubble contrast agents.
- Published in:
- WHO Drug Information, 2008, v. 22, n. 3, p. 197
- Publication type:
- Article
45
Desmopressin and hyponatraemia.
- Published in:
- WHO Drug Information, 2008, v. 22, n. 3, p. 196
- Publication type:
- Article
46
Electronic medical devices malfunction: computed tomography scanning.
- Published in:
- WHO Drug Information, 2008, v. 22, n. 3, p. 195
- Publication type:
- Article
47
Recombinant human bone morphogenetic protein: lifethreatening complications.
- Published in:
- WHO Drug Information, 2008, v. 22, n. 3, p. 195
- Publication type:
- Article
48
International Nonproprietary Names for Pharmaceutical Substances (INN).
- Published in:
- WHO Drug Information, 2008, v. 22, n. 3, p. 1
- Publication type:
- Article
49
African Medicines Regulatory Harmonization Initiative (AMRHI): a WHO concept paper.
- Published in:
- WHO Drug Information, 2008, v. 22, n. 3, p. 182
- Publication type:
- Article
50
International Harmonization.
- Published in:
- WHO Drug Information, 2008, v. 22, n. 3, p. 177
- Publication type:
- Article